Positron Emission Tomography Imaging of [ 11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A-Reference-Cited by-同舟云学术

Positron Emission Tomography Imaging of [ 11 C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A

Published:2019-07-22 Issue:5 Volume:106 Page:1056-1066
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Billington Sarah¹²,Shoner Steven³,Lee Scott⁴,Clark‐Snustad Kindra⁴^ORCID,Pennington Matthew⁵,Lewis David³,Muzi Mark³,Rene Shirley³,Lee Jean³,Nguyen Tot Bui¹,Kumar Vineet¹,Ishida Kazuya¹⁶,Chen Laigao⁷,Chu Xiaoyan⁸,Lai Yurong⁹^ORCID,Salphati Laurent¹⁰,Hop Cornelis E.C.A.¹⁰,Xiao Guangqing¹¹¹²,Liao Mingxiang¹²,Unadkat Jashvant D.¹

Affiliation:

1. Department of PharmaceuticsUniversity of Washington Seattle Washington USA

2. Drug Metabolism and PharmacokineticsVertex Pharmaceuticals (Europe) Ltd. Abingdon‐on‐Thames UK

3. Department of RadiologyUniversity of Washington Seattle Washington USA

4. Inflammatory Bowel Disease ProgramUniversity of Washington Seattle Washington USA

5. Department of Anesthesiology & Pain MedicineUniversity of Washington Seattle Washington USA

6. Pharmacokinetics and Drug MetabolismAmgen Cambridge Massachusetts USA

7. Early Clinical DevelopmentWorldwide Research and DevelopmentPfizer Inc. Cambridge Massachusetts USA

8. Pharmacokinetics, Pharmacodynamics, and Drug MetabolismMerck & Co. Kenilworth New Jersey USA

9. Department of Drug MetabolismGilead Sciences, Inc. Foster City California USA

10. Drug Metabolism and PharmacokineticsGenentech, Inc. South San Francisco California USA

11. Drug Metabolism and PharmacokineticsBiogen Cambridge Massachusetts USA

12. Department of Drug Metabolism and PharmacokineticsTakeda Pharmaceuticals International Co. Cambridge Massachusetts USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1506

Reference50 articles.

1. Corrigendum: estimation of clinical trial success rates and related parameters;Wong C.H.;Biostatistics

2. Phase II and phase III failures: 2013–2015

3. Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography

4. PET Imaging of Oatp-Mediated Hepatobiliary Transport of [11C] Rosuvastatin in the Rat

5. Regional P-Glycoprotein Activity and Inhibition at the Human Blood–Brain Barrier as Imaged by Positron Emission Tomography

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Activity of Intestinal P‐Glycoprotein and Hepatic Organic Anion Transporters Polypeptide in Pregnancy and Postpartum;The Journal of Clinical Pharmacology;2024-08-27

2. Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins;CPT: Pharmacometrics & Systems Pharmacology;2024-04-04

3. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition;Biochemical Pharmacology;2024-03

4. Performance and Sensitivity of [^99mTc]Tc-sestamibi Compared with Positron Emission Tomography Radiotracers to Measure P-glycoprotein Function in the Kidneys and Liver;Molecular Pharmaceutics;2024-01-16

5. Toward improved predictions of pharmacokinetics of transported drugs in hepatic impairment: Insights from the extended clearance model;CPT: Pharmacometrics & Systems Pharmacology;2023-10-20